US Stock MarketDetailed Quotes

IMNM Immunome

Watchlist
  • 9.400
  • +0.510+5.74%
Close Feb 28 16:00 ET
  • 9.400
  • 0.0000.00%
Post 20:01 ET
768.65MMarket Cap-1.18P/E (TTM)

About Immunome Company

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Company Profile

SymbolIMNM
Company NameImmunome
Listing DateOct 2, 2020
Issue Price12.00
Founded2006
CEODr. Clay B. Siegall,PhD
MarketNASDAQ
Employees55
Fiscal Year Ends12-31
Address18702 North Creek Parkway,Suite 100
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-425-939-7410

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Clay B. Siegall,PhD
  • Chief Executive Officer, President and Chairman of the Board
  • 14.87M
  • Sandra G. Stoneman
  • Chief Legal Officer and General Counsel
  • --
  • Bob Lechleider
  • Chief Medical Officer
  • 2.92M
  • Dr. Bruce Turner, M.D.,PhD
  • Chief Strategy Officer
  • --
  • Kinney Horn
  • Chief Business Officer
  • --
  • Max Rosett
  • Principal Accounting Officer, Executive Vice President, Operations and Interim Chief Financial Officer
  • --
  • Dr. Jack Higgins, PhD
  • Chief Scientific Officer
  • 1.84M
  • Dr. Sandra M. Swain, M.D.
  • Director
  • --
  • Philip Wagenheim
  • Director
  • 59.23K
  • Carol A. Schafer
  • Director
  • --
  • James P. Boylan, M.B.A.
  • Independent Director
  • 294.75K
  • Jean-Jacques Bienaime
  • Independent Director
  • 287.93K
  • Isaac Barchas, J.D.
  • Lead Independent Director
  • 296.59K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More